225 related articles for article (PubMed ID: 30430700)
21. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
[TBL] [Abstract][Full Text] [Related]
22. Association between a 17-gene genomic prostate score and multi-parametric prostate MRI in men with low and intermediate risk prostate cancer (PCa).
Leapman MS; Westphalen AC; Ameli N; Lawrence HJ; Febbo PG; Cooperberg MR; Carroll PR
PLoS One; 2017; 12(10):e0185535. PubMed ID: 29016610
[TBL] [Abstract][Full Text] [Related]
23. Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.
Salami SS; Ben-Levi E; Yaskiv O; Turkbey B; Villani R; Rastinehad AR
J Magn Reson Imaging; 2017 Feb; 45(2):610-616. PubMed ID: 27405584
[TBL] [Abstract][Full Text] [Related]
24. Prostate cancer lesion detection, volume quantification and high-grade cancer differentiation using cancer risk maps derived from multiparametric MRI with histopathology as the reference standard.
Gibbons M; Simko JP; Carroll PR; Noworolski SM
Magn Reson Imaging; 2023 Jun; 99():48-57. PubMed ID: 36641104
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology.
Glazer DI; Hassanzadeh E; Fedorov A; Olubiyi OI; Goldberger SS; Penzkofer T; Flood TA; Masry P; Mulkern RV; Hirsch MS; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2017 Mar; 42(3):918-925. PubMed ID: 27770164
[TBL] [Abstract][Full Text] [Related]
26. Comparing diagnostic accuracy of luminal water imaging with diffusion-weighted and dynamic contrast-enhanced MRI in prostate cancer: A quantitative MRI study.
Sabouri S; Chang SD; Goldenberg SL; Savdie R; Jones EC; Black PC; Fazli L; Kozlowski P
NMR Biomed; 2019 Feb; 32(2):e4048. PubMed ID: 30575145
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
[TBL] [Abstract][Full Text] [Related]
28. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
29. Value of T
Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
[TBL] [Abstract][Full Text] [Related]
30. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
31. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
32. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
Naiki T; Okamura T; Nagata D; Mori Y; Kawai N; Ogawa K; Akita H; Hashimoto Y; Tozawa K; Kohri K
Asian Pac J Cancer Prev; 2011; 12(4):909-13. PubMed ID: 21790224
[TBL] [Abstract][Full Text] [Related]
33. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard.
Asvadi NH; Afshari Mirak S; Mohammadian Bajgiran A; Khoshnoodi P; Wibulpolprasert P; Margolis D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2018 Nov; 43(11):3117-3124. PubMed ID: 29725743
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
35. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of Prostate Cancer by Use of MRI-Derived Quantitative Risk Maps: A Feasibility Study.
Chatterjee A; He D; Fan X; Antic T; Jiang Y; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Aug; 213(2):W66-W75. PubMed ID: 31039019
[No Abstract] [Full Text] [Related]
37. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
[TBL] [Abstract][Full Text] [Related]
38. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
[TBL] [Abstract][Full Text] [Related]
39. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.
Wu HH; Priester A; Khoshnoodi P; Zhang Z; Shakeri S; Afshari Mirak S; Asvadi NH; Ahuja P; Sung K; Natarajan S; Sisk A; Reiter R; Raman S; Enzmann D
J Magn Reson Imaging; 2019 Jan; 49(1):270-279. PubMed ID: 30069968
[TBL] [Abstract][Full Text] [Related]
40. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
